Revelation Biosciences, Inc.
REVBW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $9.99K in total; no superinvestor holds it.
Other share classesREVB
13F holders, Q1 2023
Institutional positions in Revelation Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +7 vs. Q4 2022
- Shares held
- 2.03M
- +358.5K (+21.4%) vs. Q4 2022
- Total value
- $33.4K
- +$11.9K (+55.0%) vs. Q4 2022
- New holders
- 9
- 1 more added
- Sold out
- 2
- 1 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REVBW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $9.99K |
| Q1 2026 | 11 | $6.66K |
| Q4 2025 | 11 | $10.2K |
| Q3 2025 | 11 | $13.0K |
| Q2 2025 | 12 | $13.8K |
| Q1 2025 | 9 | $10.5K |
| Q4 2024 | 11 | $6.76K |
| Q3 2024 | 13 | $18.6K |
| Q2 2024 | 14 | $25.9K |
| Q1 2024 | 12 | $36.1K |
| Q4 2023 | 12 | $20.9K |
| Q3 2023 | 14 | $31.6K |
| Q2 2023 | 12 | $30.0K |
| Q1 2023 | 17 | $33.4K |
| Q4 2022 | 11 | $23.6K |
| Q3 2022 | 12 | $123.0K |
| Q2 2022 | 17 | $208.0K |
| Q1 2022 | 18 | $389.0K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Revelation Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flow Traders U.S. LLC | 15,566 | $0 | 0.00% | +407+2.7% | Added |
| Virtu Financial LLC | 29,616 | $0 | 0.00% | +29,616 | New |
| UBS Group AG | 6,089 | $97 | 0.00% | +6,089 | New |
| Citadel Advisors LLC | 17,139 | $278 | 0.00% | +17,139 | New |
| Equitec Proprietary Markets, LLC | 20,000 | $324 | 0.00% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 44,000 | $713 | 0.00% | 00.0% | Unchanged |
| Pine Valley Investments Ltd Liability Co | 43,865 | $786 | 0.00% | +43,865 | New |
| Wolverine Asset Management LLC | 74,007 | $1.20K | 0.00% | 00.0% | Unchanged |
| Ayrton Capital LLC | 75,000 | $1.22K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 80,746 | $1.31K | 0.00% | −1,814−2.2% | Reduced |
| Cowen and Company, LLC | 98,296 | $1.59K | 0.00% | +98,296 | New |
| B. Riley Financial, Inc. | 100,000 | $1.62K | 0.00% | +100,000 | New |
| Walleye Trading LLC | 104,990 | $1.70K | 0.00% | +104,990 | New |
| Ionic Capital Management LLC | 171,189 | $2.77K | 0.00% | +171,189 | New |
| Walleye Capital LLC | 187,001 | $3.03K | 0.00% | +187,001 | New |
| Yakira Capital Management, Inc. | 246,884 | $4.00K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 715,752 | $12.8K | 0.00% | 00.0% | Unchanged |
| Owl Creek Asset Management, L.P. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −98,296−100.0% | Sold out |
| Telemetry Investments, L.L.C. | – | – | – | – | Not filed |